Viktoria Bergqvist

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/3564daf7-8a41-4872-bf35-22b428840356?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Endoscopic scoring of immune-mediated colitis disease activity
Bergqvist, Viktoria ^LU ; Gedeon, Peter ; Hertervig, Erik ^LU and Marsal, Jan ^LU (2025) In Gastrointestinal Endoscopy 101(3). p.695-696
- Contribution to journal › Letter
2024
Mark A new Simple Endoscopic Score for Ulcerative Colitis – the SES-UC
Bergqvist, Viktoria ^LU ; Gedeon, Peter ; Hertervig, Erik ^LU and Marsal, Jan ^LU (2024) In Frontiers in Gastroenterology 3.
- Contribution to journal › Article
Mark Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
Lamichhane, N. ; Melas, N. ; Bergqvist, V. ^LU ; Ekholm, N. P. ; Olén, O. ; Ludvigsson, J. F. ; Hjortswang, H. ; Marsal, J. ^LU ; Eriksson, C. and Halfvarson, J. (2024) In Digestive Diseases and Sciences 69(6). p.2175-2183
- Contribution to journal › Article
Mark Optimization of tools for monitoring, evaluating, and treating inflammatory conditions of the bowel
Bergqvist, Viktoria ^LU (2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
2022
Mark Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
Bergqvist, Viktoria ^LU ; Holmgren, Johanna ^LU ; Klintman, Daniel ^LU and Marsal, Jan ^LU (2022) In Alimentary Pharmacology and Therapeutics
- Contribution to journal › Debate/Note/Editorial
Mark Letter: to switch or not to switch, that is the question—author's reply
Bergqvist, Viktoria ^LU ; Holmgren, Johanna ^LU ; Klintman, Daniel ^LU and Marsal, Jan ^LU (2022) In Alimentary Pharmacology and Therapeutics 56(5). p.922-923
- Contribution to journal › Letter
Mark Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
Bergqvist, Viktoria ^LU ; Holmgren, Johanna ^LU ; Klintman, Daniel ^LU and Marsal, Jan ^LU (2022) In Alimentary pharmacology & therapeutics 55(11). p.1389-1401
- Contribution to journal › Article
2018
Mark Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
Bergqvist, Viktoria ^LU ; Kadivar, Mohammad ^LU ; Molin, Daniel ^LU ; Angelison, Leif ^LU ; Hammarlund, Per ; Olin, Marie ^LU ; Torp, Jörgen ; Grip, Olof ^LU ; Nilson, Stefan and Hertervig, Erik ^LU , et al. (2018) In Therapeutic Advances in Gastroenterology 11.
- Contribution to journal › Article
2017
Mark Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
Bergqvist, Viktoria ^LU ; Hertervig, Erik ^LU ; Gedeon, Peter ; Kopljar, Marija ; Griph, Håkan ; Kinhult, Sara ^LU ; Carneiro, Ana ^LU and Marsal, Jan ^LU (2017) In Cancer Immunology and Immunotherapy 66(5). p.581-592
- Contribution to journal › Article